Rafferty Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-114,006
| Closed | -$5.36M | – | 1136 |
|
|
2025
Q2 | $5.36M | Buy |
114,006
+3,080
| +3% | +$137K | 0.02% | 386 |
|
|
2025
Q1 | $4.9M | Sell |
110,926
-12,017
| -10% | -$553K | 0.02% | 379 |
|
|
2024
Q4 | $4.44M | Sell |
122,943
-15,154
| -11% | -$529K | 0.02% | 440 |
|
|
2024
Q3 | $4.42M | Sell |
138,097
-17,785
| -11% | -$664K | 0.02% | 446 |
|
|
2024
Q2 | $5.87M | Sell |
155,882
-23,684
| -13% | -$997K | 0.02% | 387 |
|
|
2024
Q1 | $8.84M | Buy |
179,566
+35,219
| +24% | +$1.63M | 0.03% | 314 |
|
|
2023
Q4 | $5.27M | Sell |
144,347
-35,237
| -20% | -$920K | 0.02% | 435 |
|
|
2023
Q3 | $4.15M | Sell |
179,584
-61,227
| -25% | -$1.67M | 0.02% | 433 |
|
|
2023
Q2 | $6.31M | Buy |
240,811
+21,982
| +10% | +$578K | 0.04% | 362 |
|
|
2023
Q1 | $5.63M | Sell |
218,829
-99,596
| -31% | -$2.91M | 0.04% | 361 |
|
|
2022
Q4 | $8.28M | Buy |
318,425
+74,061
| +30% | +$1.82M | 0.07% | 248 |
|
|
2022
Q3 | $6.97M | Buy |
244,364
+69,660
| +40% | +$2M | 0.07% | 224 |
|
|
2022
Q2 | $4.3M | Buy |
174,704
+83,875
| +92% | +$3.07M | 0.04% | 307 |
|
|
2022
Q1 | $5.13M | Buy |
90,829
+15,538
| +21% | +$889K | 0.03% | 387 |
|
|
2021
Q4 | $4.67M | Buy |
75,291
+29,718
| +65% | +$1.97M | 0.02% | 410 |
|
|
2021
Q3 | $2.89M | Buy |
45,573
+13,843
| +44% | +$1.07M | 0.02% | 501 |
|
|
2021
Q2 | $2.62M | Sell |
31,730
-10,715
| -25% | -$814K | 0.02% | 572 |
|
|
2021
Q1 | $3.12M | Buy |
42,445
+33,209
| +360% | +$2.6M | 0.02% | 462 |
|
|
2020
Q4 | $670K | Sell |
9,236
-7,484
| -45% | -$482K | 0.01% | 616 |
|
|
2020
Q3 | $797K | Buy |
+16,720
| New | +$712K | 0.01% | 610 |
|
Other funds holding SWTX
Rafferty Asset Management's SWTX Position: Q3 2025 in Review
Rafferty Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 114,006 shares — an estimated $5.36M sold.
Rafferty Asset Management first reported a position in SWTX in Q3 2020 and held it in 20 quarters. The position peaked at $8.84M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Rafferty Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Rafferty Asset Management sold 114,006 SpringWorks Therapeutics shares in Q3 2025, an estimated $5.36M.
- Rafferty Asset Management first reported a position in SpringWorks Therapeutics in Q3 2020 and held it in 20 quarters.
- Rafferty Asset Management's SpringWorks Therapeutics position peaked at $8.84M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.